Skip to content

ImmunoCAP Allergen f202, Cashew nut 14-4835-01Recalls & reported problems

Phadia AB · ImmunoCAP Allergen f202, Cashew nut · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07333066004471), received between Nov 14, 2024 and Nov 14, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

3 other recalls cover devices cleared under the same FDA submission (K051218); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information1

Patient problems

  • Anaphylactoid / Anaphylaxis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 14, 2024Insufficient Device Problem Information; Insufficient Device Problem Information

    (B)(6) REPORTED A PATIENT (CHILD) OF UNKNOWN AGE HAD AN ANAPHYLACTIC REACTION AFTER PREVIOUSLY TESTING NEGATIVE FOR IMMUNOCAP ALLERGEN F202, CASHEW NUT AND IMMUNOCAP ALLERGEN F203, PISTACHIO. A RETEST, AFTER ANAPHYLAXIS, FOR IMMUNOCAP ALLERGEN F202, CASHEW NUT AND IMMUNOCAP ALLERGEN F203, PISTACHIO WAS PERFORMED WITH POSITIVE RESULTS. THE PATIENT WAS TESTED USING IMMUNOCAP ALLERGEN F202, CASHEW NUT AND IMMUNOCAP ALLERGEN F203, PISTACHIO IN (B)(6) 2024 WITH NEGATIVE RESULTS. THE PATIENT THEN HAD AN ANAPHYLACTIC REACTION AND WAS RETESTED ON (B)(6) 2024, WHICH RESULTED IN POSITIVE RESULTS (IMMUNOCAP ALLERGEN F202, CASHEW NUT 0.84 KU/L AND IMMUNOCAP ALLERGEN F203, PISTACHIO 5.16 KU/L).

    Patient problems: Anaphylactoid / Anaphylaxis

    MAUDE report 20685965 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K051218. One submission often covers many models, so check the product and lot details in each record.

  • Z-2397-2019 · Jul 9, 2019 · Terminated
    Phadia" 1000 Model # 12-3800-01 Product Usage: The instrument is fully integrated and automated instrument including software for immunodiagnostic testing. The instrument is d
  • Z-1312-2018 · Dec 18, 2017 · Terminated
    ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human seru
  • Z-1313-2018 · Dec 18, 2017 · Terminated
    ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human s

Other SYSTEM, TEST, RADIOALLERGOSORBENT (RAST) IMMUNOLOGICAL devices

All SYSTEM, TEST, RADIOALLERGOSORBENT (RAST) IMMUNOLOGICAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page